The International Conference on Malignant Lymphoma (ICML) has become, since the first edition in 1981, a must-attend event for the scientific community involved in the study and treatment of lymphoid neoplasms.

ICML traditionally takes place in Lugano, Switzerland, and it is now organized every two years (not every three, like in the past), to allow the presentation and discussion of the most recent basic and clinical data by worldwide known hematologists, clinical oncologists, radio-oncologists, pediatricians, pathologists and leading researchers. Some of the general sessions are not focused on a specific morphologic subtype, but rather on pathways or other biological aspects, and permit therefore the presentation of basic and clinical data in the same session. 

Besides the keynote lectures named to the memory of Henry Kaplan and John Ultmann, for many years ICML had a Rappaport Lecture, devoted to more
translational and/or pathological aspects. Together with the American Association for Cancer Research (AACR), co-organizer of the lecture, we have now decided to rename it in honor of Gianni Bonadonna, passed away in September 2015, who was not only a giant in the field of lymphomas but also co-founder of ICML.

The interval between the deadline of the abstract submission, moved to March 15, and the conference has been shortened, thus allowing the inclusion of abstracts reporting the most recent results. For this reason, and also to reduce environmental impact, for the first time ICML Abstract Book will be only available online.

We invite the submission of high-quality abstracts on all aspects of lymphoid neoplasms, including multiple myeloma and CLL. Due to time constraints, only a limited number of abstracts can be selected for proffered papers (in the general sessions and in the “Focus on…” sessions). To assure a fair selection, all abstracts will be reviewed by at least 7 international experts.